VX-984
CAS No. : 1562396-65-9

VX-984
Cat. No. : CS-0034473
M. Wt. : 401.46
Size Stock Price Quantity Add to Cart Quotation Online
Products are for research use only. Not for human use. We do not sell to patients.

Bulk Inquiry

Collapse
Your information is safe with us. * Required Fields
  Salutation:
  • Dr.
  • Prof.
  • Mr.
  • Ms.
  • Mrs.
  • Miss.
*Country or Region:
  • United States
  • Canada
  • United Kingdom
  • Australia
  • China
  • Germany
  • France
  • Japan
  • Korea South
  • Switzerland
  • ----------------------------------
  • Albania
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Bolivia
  • Bosnia Herzegovina
  • Brazil
  • Bulgaria
  • Cameroon
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Estonia
  • Fiji
  • Finland
  • France
  • Georgia
  • Germany
  • Gibraltar
  • Greece
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Korea South
  • Kuwait
  • Latvia
  • Lebanon
  • Libya
  • Lithuania
  • Luxembourg
  • Macedonia
  • Malaysia
  • Malta
  • Mexico
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Nepal
  • Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Oman
  • Pakistan
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Republic of Benin
  • Romania
  • Russia
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sri Lanka
  • Suriname
  • Sweden
  • Switzerland
  • Syria
  • Thailand
  • Tunisia
  • Turkey
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Venezuela
  • Vietnam
  • Zambia
  • Zimbabwe
  • Other Countries
* Applicant name:
* Organization Name:
* Email address:
* Requested quantity:
  • mg
  • ug
  • g
  • kg
  • t
  • mL
  • L
* Phone number:
  Remarks:
 
Name, 
Organization Name, 
Email address, 
Requested quantity, 
Phone number, 
  • Data Sheet

  • Introduction

  • SDS

  • COA & Spectra

Name: VX-984; 
Cat. No. : CS-0034473
CAS No. : 1562396-65-9
Formula: C22H19D2N7O
M. Wt. : 401.46
Solubility: DMSO

Activity:

VX-984 is a selective DNA-dependent protein kinase (DNA-PK) inhibitor with IC50 of 88±64 nM for A549 lung cancer cells. IC50 & Target: IC50: 88±64 nM (DNA-PK, A549 lung cancer cells)[1]. In Vitro: VX-984 enhances the radiosensitivity of glioblastoma (GBM) cells grow in vitro. VX-984 effects on radiation-induced DNA-PKcs phosphorylation in U251 cells, a long established GBM cell line, and NSC11, a primary GBM stem-like cell line (GSC). When VX-984 is delivered 1h before irradiation there is a concentration dependent decrease in radiation induced DNA-PKcs phosphorylation in each glioma line [2]. In Vivo: Treatment of mice with VX-984 inhibites radiation-induced DNA-PKcs phosphorylation in orthotopic brain tumor xenografts, indicating that this compound crosses the blood-brain tumor barrier at sufficient concentrations. For mice bearing U251 or NSC11 brain tumors VX-984 treatment alone has no significant effect on overall survival; radiation alone increases survival. These results indicate that VX-984 enhances the radiosensitivity of brain tumor xenografts and suggest that it may be of benefit in the therapeutic management of GBM [2].

Protocol:

Cell Assay: [2]U251 cells growing in monolayer are disaggregated into a single cell suspension and seeded onto tissue culture plates. NSC11 CD133+ neurospheres are disaggregated into single cells and seeded onto tissue culture plates coated with poly-L-lysine (Invitrogen) as previously described, which allows for adherent colony formation. To evaluate radiosensitivity, cells are plated at clonal density in six-well plates and irradiated the next day. 10 to 18d after irradiation, plates are stained with 0.5% crystal violet, the number of colonies determined, and the surviving fractions are calculated. Radiation survival curves are generated after normalizing for the cytotoxicity induced by VX-984 (100 nM,250 nM), respectively[2].
Animal Administration: VX-984 is dissolved in freshly made 5% methylcellulose[2].[2]U251 (2.5×105) cells or CD133+ NSC11 cells (1.0×105),transduces to express luciferase and GFP with the lentivirus LVpFUGQ-UbC-ffLuc2-eGFP2 are intracranially implanted into the right striatum of 6-8-week-old athymic female nude mice. VX-984 (100 mg/kg) is delivered by oral gavage at 1 or 4 h prior to irradiation; 1 h after irradiation tumors are harvested and subjected to immunoblot analysis[2].

References:

Harnor SJ, et al. Targeting DNA-Dependent Protein Kinase for Cancer Therapy. ChemMedChem. 2017 Jun 21; 12(12):895-900.

Timme CR, et al. The DNA-PK inhibitor VX-984 enhances the radiosensitivity of glioblastoma cells grown in vitro and as orthotopic xenografts. Rath BH, O'Neill JW, Camphausen K, Tofilon PJ. Mol Cancer Ther. 2018 Jun; 17(6):1207-1216.

  • Select Batch :
Browsing History
Tags:VX-984 supplier,VX-984 purchase,VX-984 manufacturer,VX-984 sigma,VX-984 distributor,cost,VX-984 buy,VX-984 for sale
Please enter your email address
Organization name: Email:

Submit success